Cardiovascular Systems EBIT

As of the most recent data (December 2022), CSII shows a EBIT of $-39M. That compares with $-27M in the prior-year period — down 41.6% year over year. That is below the Healthcare sector average of $23B. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, CSII's EBIT is now $-39M (was $-27M) — a 41.6% year-over-year decrease. Pairing that YoY change with peer averages gives a clearer picture of whether Cardiovascular Systems is outperforming or lagging.

The Healthcare sector average EBIT is about $23B. Cardiovascular Systems is at $-39M, which is lower that average. That is roughly 100.2% below the sector mean. Use the comparison chart on this page to see how CSII stacks up against individual peers as well.

Tracking CSII's ebit over time shows whether Cardiovascular Systems is scaling, shrinking, or reshaping that part of the business. The current reading is $-39M That compares with $-27M in the prior-year period — down 41.6% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this ebit page, Stockcircle has Cardiovascular Systems's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect EBIT (currently $-39M) with ownership activity and broader fundamentals.